Peters: Superpower rejected a $2M domain offer from an AI startup
Jacob Peters · Superpower Raises $30M Series A Led by Forerunner · Sourcery with Molly O'Shea · Apr 22, 2025 · at 8:43
Jacob Peters, founder and CEO of healthcare startup Superpower, describes acquisition interest in the company's domain name from a competitor.
0:00 / 0:04exact quote · 4.8s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Yeah, and I've been offered over two million for it by a well-funded AI company, which I will not name.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Jacob Peters
Peters: Consumers will disintermediate traditional healthcare using AI pocket doctors
“In the limit, we think every person in America, and frankly the world, will have an AI doctor in their pocket, and consumers will fully disintermediate the existing healthcare system as it stands.”
Peters: As AI makes replication easy, brand is the most powerful moat
“In a world where, you know, AI and vibe coding is only proliferating and making it easier to replicate products, brand is possibly one of the most powerful motes and defensible aspects of a business.”
Peters: Nearly 85% of US health system revenue comes from drugs and surgery
“In America, close to 85% of health system revenue comes from two sources.
Do you know what those are?
Tell us.
Pharmaceuticals and surgery.”
Peters: Foundation models eliminate compute constraints in medicine
“With the advancement of foundation models compute is no longer a constraint in medicine, which has opened up this market opportunity in this portal for healthcare to really be built as a product.”
Peters: The largest consumer health companies will own fintech and underwriting
“What does the biggest health consumer health company in the world look like?
And it's probably some combination of,
Becoming the fintech layer and owning the, you know, insurance and the underwriting, the ability to actually cover and figure out, you know, t…”
Peters: Biologic drugs generate roughly $15,000 per patient monthly for life
“TNF alpha immune system modulator, which is like a called a biologic drug. It's a class of biologic drugs that modulate your immune system. They make, they generate like 15 K a month and you are on them for life typically.”